Passa al contenuto
Merck
  • Hypothyroidism-related onycholysis with Aureobasidium pullulans colonization successfully treated with antifungal therapy.

Hypothyroidism-related onycholysis with Aureobasidium pullulans colonization successfully treated with antifungal therapy.

Clinical and experimental dermatology (2012-03-24)
M Arabatzis
ABSTRACT

This is a report, the first to my knowledge, of secondary nail-apparatus involvement by Aureobasidium pullulans in a patient with onycholysis related to hypothyroidism. Complete cure of the lesions was seen after 2 weeks of itraconazole and 2 months of local bifonazole therapy. This case raises concern about the extent of involvement of this yeast in onycholysis of diverse clinical aetiologies.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Bifonazole, ≥98% (HPLC)
Supelco
Bifonazole, Pharmaceutical Secondary Standard; Certified Reference Material
Bifonazole, European Pharmacopoeia (EP) Reference Standard